{"id":3527,"date":"2022-09-05T19:23:03","date_gmt":"2022-09-05T19:23:03","guid":{"rendered":"https:\/\/palynziqhcp-dev-001.azurewebsites.net\/en-us\/palynziq\/?page_id=3527"},"modified":"2024-06-12T13:37:42","modified_gmt":"2024-06-12T13:37:42","slug":"dosing-and-administration-video","status":"publish","type":"page","link":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/","title":{"rendered":"Dosing And Administration &#8211; Video"},"content":{"rendered":"<div id=\"acf-block-63f656f5a0eb4\" class=\"block split-content equal-bias content-align-top bottom-border\" data-muted-autoplay=\"false\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t                                                                <div class=\"content-block first-block\">\n                                                                                                                                                                                                                                                <div class=\"video-poster\">\n\t\t\t                            <a class=\"modal-video permitted\" href=\"https:\/\/player.vimeo.com\/video\/664755888\" style=\"background-image: url(https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-content\/uploads\/sites\/3\/2022\/12\/Dosing-video-1500x828.png);\">Play<\/a>\n\t\t                            <\/div>\n\t\t                                                                            <\/div>\n                    \n                                            <div class=\"content-block second-block\">\n                                                                                                <h5>PALYNZIQ<sup>\u00ae<\/sup> (pegvaliase-pqpz) Injection<br \/>\nA Phe-lowering Enzyme Therapy for Adults With PKU<\/h5>\n<p><small>For Healthcare Professionals<\/small><\/p>\n<p><strong>Dosing and Administration<\/strong><\/p>\n<p>Dr. Barbara Burton and Heather Bausell, RD, LDN, share dosing and administration considerations when using PALYNZIQ in eligible adult patients with PKU. They explain the ability to individualize PALYNZIQ therapy, including dose options up to 60 mg once daily.<\/p>\n<p><strong>Indication<\/strong><\/p>\n<p>PALYNZIQ is a phenylalanine (Phe)-metabolizing enzyme indicated to reduce blood Phe concentrations in adult patients with phenylketonuria who have uncontrolled blood Phe-concentrations greater than 600 micromol\/L on existing management.<\/p>\n<p><strong>Please see full <a href=\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-content\/uploads\/sites\/3\/2022\/08\/prescribinginformation.pdf?v=0.5\">Prescribing Information<\/a>, with Boxed Warning for risk of anaphylaxis, and Medication Guide, <a href=\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/important-safety-information\/\">here<\/a>.<\/strong><\/p>\n<p><a href=\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/clinical-practice-with-palynziq-video\/\">Next Video<\/a><\/p>\n                                                                                    <\/div>\n                                                \t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"acf-block-63f656f5a0f14\" class=\"block wrapped-content\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                        <\/div>\n    <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-3527","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dosing and Administration Video | Palynziq HCP<\/title>\n<meta name=\"description\" content=\"Dr. Barbara Burton and Heather Bausell, RD, LDN, share dosing and administration considerations when using PALYNZIQ in eligible adult patients with PKU.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dosing and Administration Video | Palynziq HCP\" \/>\n<meta property=\"og:description\" content=\"Dr. Barbara Burton and Heather Bausell, RD, LDN, share dosing and administration considerations when using PALYNZIQ in eligible adult patients with PKU.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/\" \/>\n<meta property=\"og:site_name\" content=\"BioMarin Palynziq HCP EN-US\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-12T13:37:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/\",\"url\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/\",\"name\":\"Dosing and Administration Video | Palynziq HCP\",\"isPartOf\":{\"@id\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/#website\"},\"datePublished\":\"2022-09-05T19:23:03+00:00\",\"dateModified\":\"2024-06-12T13:37:42+00:00\",\"description\":\"Dr. Barbara Burton and Heather Bausell, RD, LDN, share dosing and administration considerations when using PALYNZIQ in eligible adult patients with PKU.\",\"breadcrumb\":{\"@id\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dosing And Administration &#8211; Video\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/#website\",\"url\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/\",\"name\":\"BioMarin Palynziq HCP EN-US\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dosing and Administration Video | Palynziq HCP","description":"Dr. Barbara Burton and Heather Bausell, RD, LDN, share dosing and administration considerations when using PALYNZIQ in eligible adult patients with PKU.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/","og_locale":"en_US","og_type":"article","og_title":"Dosing and Administration Video | Palynziq HCP","og_description":"Dr. Barbara Burton and Heather Bausell, RD, LDN, share dosing and administration considerations when using PALYNZIQ in eligible adult patients with PKU.","og_url":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/","og_site_name":"BioMarin Palynziq HCP EN-US","article_modified_time":"2024-06-12T13:37:42+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/","url":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/","name":"Dosing and Administration Video | Palynziq HCP","isPartOf":{"@id":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/#website"},"datePublished":"2022-09-05T19:23:03+00:00","dateModified":"2024-06-12T13:37:42+00:00","description":"Dr. Barbara Burton and Heather Bausell, RD, LDN, share dosing and administration considerations when using PALYNZIQ in eligible adult patients with PKU.","breadcrumb":{"@id":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/dosing-and-administration-video\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/"},{"@type":"ListItem","position":2,"name":"Dosing And Administration &#8211; Video"}]},{"@type":"WebSite","@id":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/#website","url":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/","name":"BioMarin Palynziq HCP EN-US","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/pages\/3527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/comments?post=3527"}],"version-history":[{"count":62,"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/pages\/3527\/revisions"}],"predecessor-version":[{"id":6689,"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/pages\/3527\/revisions\/6689"}],"wp:attachment":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/palynziq\/wp-json\/wp\/v2\/media?parent=3527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}